Haemochromatosis: An inherited metal and toxicity syndrome

Current Opinion in Genetics and Development

Volumn 8, Issue 3, 1998, Pages 274-281

  Cox, Timothy M ^a   Kelly, Alison L ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; BETA 2 MICROGLOBULIN; CYSTEINE; HISTIDINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TRANSFERRIN RECEPTOR; TYROSINE;

ALLELE; CHROMOSOME 6P; DISORDERS OF METAL METABOLISM; HEMOCHROMATOSIS; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TELOMERE; TOXICITY;

EID: 0032102719     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(98)80081-6     Document Type: Article

References (61)

1. DeMaeyer E, Adiels-Tegman M. The prevalence of anaemia in the world. World Health Statistics Quart. 38:1985;302-316.
2. Edwards CO, Griffin LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of haemochromatosis among 11065 presumably healthy blood donors. N Engl J Med. 318:1988;1355-1362.
3. Gutteridge JMC, Rowley DA, Griffiths E, Halliwell B. Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clin Sci. 68:1985;463-467.
4. Sheldon JH. Haemochromatosis. 1935;Clarendon Press, London.
5. Bothwell TH, Charlton RW, Motulsky AG. Hemochromatosis. Scriver CR, Beaudet AL, Sly WS, Valle D. 7 The Metabolic and Molecular Bases of Inherited Disease. 1995;2237-2269 Mc-Graw Hill, New York.
6. Niederau C, Fischer R, Sonnenburg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and non-cirrhotic patients with primary hemochromatosis. New Engl J Med. 313:1985;1256-1262.
7. Cazzola M, Ascari E, Barosi G, Claudini G, Daccó M, Kaltwasser JP, Panaiofopoulos N, Schalk KP, Werner EE. Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism. Hum Genet. 65:1983;149-154.
8. Weatherall DJ, Clegg JB. 3 The Thalassaemia Syndromes. 1981;Blackwell Scientific Publications, Oxford.
9. McCance RA, Widdowson EM. Absorption and excretion of iron. Lancet. 233:1937;680-684.
10. Hershko C, Graham G, Bates GW, Rachmilewitz EA. Non-specific serum iron fraction of potential toxicity. Brit J Haematol. 40:1978;255-263.
11. Hayashi A, Wada Y, Suzuki T, Shimizu A. Studies on familial hypotransferrinemia: unique clinical course and molecular pathology. Am J Hum Genet. 53:1993;201-213.
12. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R, Ellis MC, Fullan A, et al. A novel MHC class 1-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 13:1996;399-408.
13. Beutler E. The significance of the 187 G (H63D, mutation in hemochromatosis. Am J Hum Genet. 61:1997;762-764.
14. Bjorkman PJ, Parham P. Structure, function and diversity of Class I major histocompatibility complex molecules. Annu Rev Biochem. 59:1990;253-288.
15. 2-micoglobulin deficient mice. Immunol Lett. 39:1994;105-111.
16. 2-microglobulin interactions and thus cell surface expression of a functional non-classical MHC Class I molecule.
17. 2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. of outstanding interest Proc Natl Acad Sci USA. 94:1997;12384-12388 See annotation [16].
18. Parkkila S, Waheed A, Britton RS, Feder JN, Tsuchihashi Z, Schatzman RC, Bacon BR, Sly WS. Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract. of outstanding interest Proc Natl Acad Sci USA. 94:1997;2534-2539 Although the molecular function of HFE is not yet completely understood, its pattern of expression - especially within the cells of the upper intestinal mucosa in which iron regulatory activity is invested - will bear importantly on its interactions with the absorptive mechanism concerned with iron transport.
19. Young ACM, Nathenson SG, Sacchettini JC. Structural studies of Class I major histocompatibility complex proteins: insights into antigen presentation. FASEB J. 9:1995;26-36.
20. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T. Cell stress-regulated human major histocompability complex Class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA. 93:1996;12445-12450.
21. 2-microglobulin knockout mice recapitulates hereditary haemochromatosis in man. of outstanding interest J Exp Med. 184:1996;1975-1985 Detailed mouse studies here indicate some of the defects of iron metabolism that occur in human haemochromatosis. Definitive proof for HFE causality in iron regulation in the specific HFE knockout animal is provided in [61].
22. Hashimoto K, Hirai M, Kurosawa Y. Identification of a mouse homologue for the human hereditary haemochromatosis candidate gene. of special interest Biochem Biophys Res Commun. 230:1997;35-39 This report indicates that the evolutionary conservation of the unusual HFE gene - a modified class I MHC gene homologue - has been adapted for a distinct role in the control of iron metabolism. See also [61] for a description of murine HFE knockout.
23. Munro HN, Linder MC. Ferritin: structure, biosynthesis and role in iron metabolism. Physiol Rev. 58:1978;318-396.
24. Casey JL, Hentze MW, Koeller DM, Caughman SW, Roualt TA, Klausner RD, Harford JB. Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation. Science. 240:1988;924-928.
25. Hentze MW, Argos P. Homology between IRE-BP, a regulatory RNA-binding protein, aconitase and isopropylmalate isomerase. Nucleic Acids Res. 19:1991;1739-1740.
26. Cox TC, Bawden MJ, Martin A, May BK. Human erythroid δ-aminolevulinate synthase: promoter analysis and identification of an iron-responsive element in the mRNA. EMBO J. 10:1991;1891-1902.
27. Pietrangelo P, Casalgrandi G, Quaglino D, Gualdi R, Conte D, Milani S, Montosi G, Cesarini L, Ventura E, Cairo G. Duodenal ferritin synthesis in genetic hemochromatosis. Gastroenterol. 108:1995;208-217.
28. Bomford AB, Conlon-Hollingshead C, Munro HN. Adaptive responses of rat tissue isoferritins to iron administration. Changes in subunit synthesis, isoferritin abundance and capacity for storage iron. J Biol Chem. 256:1982;948-955.
29. Pietrangelo P, Rocchi E, Casalgrandi G, Rigo G, Ferrari A, Perini M, Ventura E, Cairo G. Regulation of transferrin, transferrin receptor and ferritin genes in human duodenum. Gastroenterol. 102:1992;802-809.
30. Feder JN, Penny DM, Irrinki A, Lee VK, Lebrón JA, Watson N, Tsuchihashi Z, Sigal E, Bjorkman PJ, Schatzman RA. The haemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. of outstanding interest Proc Natl Acad Sci USA. 95:1998;1473-1477 A tantalising publication showing for the first time that HFE protein interacts directly with an iron transport protein, presumably effecting allosteric control of ligand binding - a process that is disrupted by the H63D mutation the role of which has been doubled. If confirmed, this discovery may provide the key to our understanding of HFE function and the regulation of iron metabolism.
31. Osaki S, Johnson DA, Frieden E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J Biol Chem. 241:1966;2746-2751.
32. Roeser HP, Lee GT, Nacht S, Cartwright GE. The role of ceruloplasmin in iron metabolism. J Clin Invest. 49:1970;2408-2417.
33. Stearman R, Yuan DA, Yamaguchi-Iwai Y, Klausner RD, Dancis A. A permease-oxidase complex involved in high-affinity iron uptake in yeast. of special interest Science. 271:1996;1552-1557 Interesting Cu/Fe transport protein relationship identified by genetic manipulation in yeast; a gene with homology to mammalian caeruloplasmin mediates high-affinity iron uptake by individual yeast cells.
34. Logan JI, Harveyson KB, Wisdom GB, Hughes AE, Archbold GPR. Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus. QOJ Med. 87:1994;663-670.
35. Mukhopadhyay CK, Attieh ZK, Fox PL. Role of ceruloplasmin in cellular iron uptake. of special interest Science. 279:1998;714-717 Novel in vitro studies on the putative allosteric control of iron transport by the copper ferroxidase protein, caeruloplasmin.
36. Fleming MD, Trenor CC, Su MA, Foernzler D, Beier DR, Dietrich WF, Andrews NC. Microcytic anaemia mice have a mutation in Nramp 2, a candidate iron transporter gene. of special interest Nat Genet. 16:1997;383-386 Elegant paper reporting the identification of Nramp2 as the putative mammalian transporter of iron by microvillar intestinal membranes and erythroblasts.
37. Vidal SM, Malo D, Vogan K, Skamene E, Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell. 73:1993;469-485.
38. Cellier M, Belouchi A, Gros P. Resistance to intracellular infections: comparative genomic analysis of Nramp. Trends Genet. 12:1996;201-204.
39. Grunheid S, Cellier M, Vidal S, Gros P. Identification and characterization of a second mouse Nramp gene. Genomics. 25:1995;514-525.
40. Supek F, Supekova L, Nelson H, Nelson N. A yeast manganese transporter related to the macrophage protein involved in conferring resistance to mycobacteria. Proc Natl Acad Sci USA. 93:1996;5105-5110.
41. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Hediger MA. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. of outstanding interest Nature. 388:1997;482-488 Independent discovery of the transporter DCT 1 - the rat homologue of human and murine Nramp 2 - identity of which was confirmed by functional cloning using the laborious Xenopus oocyte system.
42. Cox TM, Peters TJ. Uptake of iron by duodenal biopsy specimens from patients with iron deficiency and primary haemochromatosis. Lancet. 1:1978;123-124.
43. Duane P, Raja KB, Simpson RJ, Peters TJ. In vitro uptake of iron from iron-ascorbate by human duodenal biopsies from control subjects and patients with idiopathic haemochromatosis. Eur J Gastroenterol Hepatol. 4:1992;661-666.
44. Cox TM. Prevalence of the hemochromatosis gene. N Engl J Med. 302:1980;695-696.
45. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys 282 Tyr mutation in sporadic porphyria cutanes tarda. of special interest Lancet. 349:1997;321-323 See annotation [46].
46. Yaounq J, Grosbois B, Jouanolle AM, Goasguen J, Leblay R. Haemochromatosis Cys282Tyr mutation in pyridoxine-responsive sideroblastic anaemia. of special interest Lancet. 349:1997;1475-1476 Other disorders to which HFE mutations contribute, presumably by predisposing to excessive iron absorption.
47. Rhodes DA, Raha-Chowdhury K, Cox TM, Trowsdale J. Homozygosity for the predominant Cys282Tyr mutation and absence of disease expression in hereditary haemochromatosis. of special interest J Med Genet. 34:1997;761-764 Homozygosity for the HFE C282Y is not tantamount to haemochromatosis - why?
48. Knisely AS. Neonatal hemochromatosis. Adv Pediatr. 39:1992;383-403.
49. Camaschella C, Roetto A, Cicilano M, Pasquero P, Bosio S, Gubetta L, Di Vito F, Girelli D, Totaro A, Carella M, et al. Juvenile and adult haemochromatosis are distinct genetic disorders. of special interest Eur J Hum Genet. 5:1997;371-375 Clear identification of non-chromosome 6p determinants of severe iron-storage disease: genetic heterogeneity and a severe phenotype (see [52]) promises further revelations about the mechanism.
50. Takahasi Y, Miyajima H, Shirabe S, Nagataki S, Suenaga A, Gitlin JD. Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease. Hum Mol Genet. 5:1995;81-84.
51. Gordeuk VR, Mukibi J, Hasstedt SJ, Samowitz W, Edwards CO, West G, Ndambire S, Emmual J, Nkanza J, Chapanduka Z, et al. Iron overload in Africa: interaction between a gene and dietary iron content. N Engl J Med. 326:1992;95-100.
52. Cazzola M, Ascari E, Barosi G, Claudiani G, Dacco M, Kaltwasser JP, Panaiotopoulos N, Schalk KP, Werner EE. Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism. Hum Genet. 65:1983;149-154.
53. Silver MM, Beverley DW, Valberg LS, Cutz E, Phillips MJ, Shaheed WI. Perinatal hemochromatosis. Clinical, morphologic and quantitative iron studies. Am J Pathol. 128:1987;538-554.
54. Bale PM, Kan AE, Dorney SFA. Renal proximal tubular dysgenesis associated with severe neonatal hemosiderotic liver disease. Ped Pathol. 14:1994;479-489.
55. Verloes A, Lombet J, Lambert Y. Tricho-hepato-enteric syndrome: further delineation of a distinct syndrome with neonatal hemochromatosis phenotype, intractable diarrhea, and hair anomalies. Am J Med Genet. 68:1997;391-395.
56. Fellman V, Rapola J, Pihko H, Varilo T, Raivio KO. Iron-overload disease in infants involving fetal growth retardation, lactic acidosis, liver haemosiderosis and aminoaciduria. Lancet. 351:1998;490-493.
57. Bannerman RM. Genetic defects of iron transport. Fed Proc. 35:1976;2281-2285.
58. Waheed A, Grubb JH, Zhou XY, Tomatsu S, Fleming RE, Parkkila S, Jiang J, Fei Y, Brunt EM, Ruddy EA, et al. Function of the HFE gene product. Molecular Medicine and Hemochromatosis. 1998;28. Bethesda, Maryland: National Institutes of Health Symposium Proceedings; May 14-15.
59. Lèbron JA, Bennett MJ, Vaughn DE, Chirino AJ, Snow PM, Mintier GA, Feder JN, Bjorkman PJ. Crystal structure of the hemochromatosis protein HFE and characterisation of its interaction with transferrin receptor. of outstanding interest Cell. 93:1998;111-123 This impressive paper describes the crystal structure of a truncated recombinant HFE molecule. Although a putative metal-binding domain containing a histidine cluster was identified, the purification of the recombinant protein involving a denaturation procedure prevented the demonstration of tightly-bound metal ions. No peptides were identified in the Class I binding groove. Provocative findings suggesting the in vitro formation of a ternary HFE/transferrin receptor/iron-saturated transferrin complex are reported.
60. Bernstein SE. Hereditary hypotransferrinaemia with hemosiderosis, a murine disorder resembling human atransferrinaemia. J Lab Clin Med. 110:1987;690-705.
61. Zhou XY, Tomatsu S, Fleming RE, Parkkila S, Waheed A, Jiang J, Fei Y, Brunt EM, Ruddy DA, Prass CE, et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. of outstanding interest Proc Natl Acad Sci USA. 95:1998;2492-2497 The definitive experiment: disruption of the murine HFE exon 4 region by homologous recombination leads to the development of tissue iron storage in homozygous mice fed a normal diet by the age of 10 weeks.